3/25/2021

Children's Hospital Los Angeles Hemostasis and Thrombosis Center, Los Angeles, CA

Pediatric Hemostasis and Thrombosis Fellowship 

The Pediatric Hemostasis and Thrombosis Fellowship at the Children’s Hospital Los Angeles Hemostasis and Thrombosis Center (HTC) is designed to provide an additional 1-2 years of training specific to pediatric coagulation disorders following completion of a pediatric hematology/oncology fellowship. The objectives of the fellowship are to provide advanced training in the diagnosis and treatment of children and young adults with bleeding and thrombotic disorders including hemophilia, von Willebrand disease, platelet function disorders, rare factor deficiencies as well as venous and arterial thrombosis. In addition, the fellow is expected to participate in the extensive clinical research program and will be given the opportunity to conduct his/her own research study.

As one of the largest pediatric hemostasis and thrombosis treatment centers in the world, the HTC is a recognized international leader in patient care, clinical research and education and has both the clinical and laboratory resources to provide an in-depth training in coagulation. The center has over 800 patients with bleeding disorders (over 400 with hemophilia) and each year well over 100 new patients with venous thromboembolism are diagnosed.

HTC Features:

  • One of the first HTCs supported and designated by the Federal Government in the United States
  • Continues to be the largest HTC in California since 1976, as well as the largest coagulation center in the western U.S.
  • Provides comprehensive care to more than 800 patients with bleeding and clotting disorders, and cares for one of the largest populations of hemophilia patients with inhibitors in the world
  • Receives over 200 new patient referrals each year, including adult patients
  • Serves as an international referral center for children with hemostasis and thrombosis disorders
  • Conducts cutting-edge research of new treatments for bleeding and clotting disorders

The HTC conducts numerous research projects ranging from NIH- and FDA-funded clinical trials to industry-sponsored clinical trials to center-based projects primarily focusing on thromboelastography and thrombin generation assays for the management of patients with bleeding and clotting disorders. In addition, there are several observational and epidemiologic studies currently under way. Lastly, the center is part of the American Thrombosis and Hemostasis Network (ATHN) and receives funding from the Centers for Disease Control (CDC) to participate in its network of HTCs.

The fellowship is mentored by Dr. Guy Young, a recognized international leader in the field of pediatric coagulation disorders, and is supported by an outstanding multi-disciplinary team of experts.

Interested candidates should send a copy of their CV, a personal statement, and three letters of recommendation to Dr. Guy Young at [email protected].
 

Application Deadline: July 1, 2021, or until position is filled

Fellowship announcement

top